A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 6,915 shares of DGX stock, worth $947,977. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,915
Previous 6,797 1.74%
Holding current value
$947,977
Previous $930,000 15.38%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$137.09 - $137.09 $16,176 - $16,176
118 Added 1.74%
6,915 $1.07 Million
Q2 2024

Jul 26, 2024

SELL
$125.91 - $144.34 $495,078 - $567,544
-3,932 Reduced 36.65%
6,797 $930,000
Q1 2024

Apr 24, 2024

SELL
$123.78 - $142.11 $9,159 - $10,516
-74 Reduced 0.68%
10,729 $1.43 Million
Q4 2023

Feb 09, 2024

SELL
$120.62 - $141.12 $45,594 - $53,343
-378 Reduced 3.38%
10,803 $1.49 Million
Q3 2023

Oct 24, 2023

SELL
$121.86 - $144.92 $3.11 Million - $3.7 Million
-25,544 Reduced 69.55%
11,181 $1.36 Million
Q2 2023

Jul 13, 2023

BUY
$130.56 - $146.84 $3.78 Million - $4.25 Million
28,953 Added 372.53%
36,725 $5.16 Million
Q1 2023

May 11, 2023

SELL
$131.53 - $155.76 $38,932 - $46,104
-296 Reduced 3.67%
7,772 $1.1 Million
Q4 2022

Feb 08, 2023

SELL
$123.31 - $157.26 $22,689 - $28,935
-184 Reduced 2.23%
8,068 $1.26 Million
Q3 2022

Oct 17, 2022

SELL
$121.77 - $141.1 $733,055 - $849,422
-6,020 Reduced 42.18%
8,252 $1.01 Million
Q2 2022

Jul 13, 2022

BUY
$127.07 - $145.39 $354,779 - $405,928
2,792 Added 24.32%
14,272 $1.9 Million
Q1 2022

May 12, 2022

SELL
$129.09 - $164.35 $440,713 - $561,090
-3,414 Reduced 22.92%
11,480 $1.57 Million
Q4 2021

Feb 03, 2022

SELL
$140.36 - $173.01 $545,719 - $672,662
-3,888 Reduced 20.7%
14,894 $2.58 Million
Q3 2021

Nov 02, 2021

BUY
$132.95 - $158.0 $637,761 - $757,926
4,797 Added 34.3%
18,782 $2.73 Million
Q2 2021

Aug 10, 2021

BUY
$126.66 - $141.48 $40,277 - $44,990
318 Added 2.33%
13,985 $1.85 Million
Q1 2021

May 07, 2021

BUY
$114.63 - $133.34 $409,458 - $476,290
3,572 Added 35.38%
13,667 $1.75 Million
Q4 2020

Feb 04, 2021

SELL
$112.7 - $128.05 $132,647 - $150,714
-1,177 Reduced 10.44%
10,095 $1.2 Million
Q3 2020

Oct 29, 2020

SELL
$107.05 - $130.01 $3.78 Million - $4.59 Million
-35,316 Reduced 75.8%
11,272 $1.29 Million
Q2 2020

Jul 27, 2020

SELL
$73.34 - $122.61 $575,645 - $962,365
-7,849 Reduced 14.42%
46,588 $5.31 Million
Q1 2020

May 08, 2020

BUY
$75.14 - $115.68 $154,863 - $238,416
2,061 Added 3.94%
54,437 $4.37 Million
Q4 2019

Feb 04, 2020

BUY
$100.29 - $107.99 $451,004 - $485,631
4,497 Added 9.39%
52,376 $5.59 Million
Q3 2019

Nov 06, 2019

BUY
$97.85 - $107.42 $213,704 - $234,605
2,184 Added 4.78%
47,879 $5.12 Million
Q3 2019

Oct 28, 2019

SELL
$97.85 - $107.42 $13,796 - $15,146
-141 Reduced 0.31%
45,695 $4.89 Million
Q2 2019

Aug 15, 2019

BUY
$85.18 - $101.94 $209,287 - $250,466
2,457 Added 5.66%
45,836 $0
Q1 2019

May 08, 2019

BUY
$80.68 - $89.92 $3.11 Million - $3.46 Million
38,490 Added 787.28%
43,379 $0
Q4 2018

Feb 05, 2019

SELL
$79.75 - $108.38 $2.62 Million - $3.56 Million
-32,850 Reduced 87.05%
4,889 $407,000
Q3 2018

Nov 02, 2018

BUY
$105.42 - $114.99 $65,676 - $71,638
623 Added 1.68%
37,739 $0
Q2 2018

Aug 10, 2018

SELL
$97.35 - $113.14 $52,179 - $60,643
-536 Reduced 1.42%
37,116 $0
Q1 2018

May 09, 2018

BUY
$96.42 - $107.88 $147,619 - $165,164
1,531 Added 4.24%
37,652 $0
Q4 2017

Feb 22, 2018

BUY
$90.86 - $100.24 $305,198 - $336,706
3,359 Added 10.25%
36,121 $0
Q3 2017

Nov 07, 2017

SELL
$91.96 - $108.35 $31,450 - $37,055
-342 Reduced 1.03%
32,762 $3.07 Million
Q2 2017

Aug 08, 2017

BUY
N/A
33,104
33,104 $3.68 Million

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.